Codexis Ownership

CDXS Stock  USD 2.88  0.02  0.70%   
Codexis holds a total of 82.84 Million outstanding shares. The majority of Codexis outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Codexis to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Codexis. Please pay attention to any change in the institutional holdings of Codexis as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2007-03-31
Previous Quarter
81.3 M
Current Value
82.4 M
Avarage Shares Outstanding
45.2 M
Quarterly Volatility
20.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Codexis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy Codexis Stock please use our How to Invest in Codexis guide.

Codexis Stock Ownership Analysis

About 84.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.98. Codexis had not issued any dividends in recent years. Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people. For more info on Codexis please contact Stephen MBBS at 650 421 8100 or go to https://www.codexis.com.
Besides selling stocks to institutional investors, Codexis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Codexis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Codexis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Codexis Quarterly Liabilities And Stockholders Equity

128.89 Million

Codexis Insider Trades History

Roughly 2.0% of Codexis are currently held by insiders. Unlike Codexis' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Codexis' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Codexis' insider trades
 
Credit Downgrade
 
Yuan Drop
 
Covid

Codexis Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Codexis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Codexis backward and forwards among themselves. Codexis' institutional investor refers to the entity that pools money to purchase Codexis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Pier Capital, Llc2025-03-31
1.7 M
State Street Corp2025-03-31
1.6 M
Nuveen, Llc2025-03-31
1.2 M
Federated Hermes Inc2025-03-31
1.1 M
Jacobs Levy Equity Management, Inc.2025-03-31
1.1 M
Northern Trust Corp2025-03-31
663 K
Renaissance Technologies Corp2025-03-31
650.8 K
Aberdeen Group Plc2025-03-31
606.3 K
Assenagon Asset Management Sa2025-03-31
602.3 K
Opaleye Management Inc2025-03-31
9.5 M
Casdin Capital, Llc2025-03-31
8.1 M
Note, although Codexis' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Codexis Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Codexis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Codexis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Codexis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Opaleye Management Inc. over a month ago
Acquisition by Opaleye Management Inc. of 50898 shares of Codexis at 2.24 subject to Rule 16b-3
 
Opaleye Management Inc. over a month ago
Acquisition by Opaleye Management Inc. of 99102 shares of Codexis at 2.23 subject to Rule 16b-3
 
Opaleye Management Inc. over a month ago
Acquisition by Opaleye Management Inc. of 100000 shares of Codexis at 2.25 subject to Rule 16b-3
 
Collins Cynthia over a month ago
Acquisition by Collins Cynthia of 40983 shares of Codexis subject to Rule 16b-3
 
Opaleye Management Inc. over a month ago
Acquisition by Opaleye Management Inc. of 5000 shares of Codexis at 2.36 subject to Rule 16b-3
 
Opaleye Management Inc. over a month ago
Acquisition by Opaleye Management Inc. of 2320000 shares of Codexis at 2.36 subject to Rule 16b-3
 
Georgia Erbez over a month ago
Acquisition by Georgia Erbez of 300000 shares of Codexis at 2.97 subject to Rule 16b-3
 
Opaleye Management Inc. over two months ago
Acquisition by Opaleye Management Inc. of 25000 shares of Codexis at 2.3064 subject to Rule 16b-3
 
Opaleye Management Inc. over two months ago
Acquisition by Opaleye Management Inc. of 25000 shares of Codexis at 2.2366 subject to Rule 16b-3
 
Opaleye Management Inc. over three months ago
Acquisition by Opaleye Management Inc. of 45000 shares of Codexis at 2.0925 subject to Rule 16b-3
 
Opaleye Management Inc. over three months ago
Acquisition by Opaleye Management Inc. of 25000 shares of Codexis at 2.2288 subject to Rule 16b-3
 
Opaleye Management Inc. over three months ago
Acquisition by Opaleye Management Inc. of 100000 shares of Codexis at 1.9838 subject to Rule 16b-3

Codexis Outstanding Bonds

Codexis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Codexis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Codexis bonds can be classified according to their maturity, which is the date when Codexis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Codexis Stock Analysis

When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.